Retinoic acid-induced survival effects in SH-SY5Y neuroblastoma cells

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Neuroblastoma is a significant childhood cancer originating from neural crest cells.
• Retinoic acid (RA) therapy is crucial for high-risk neuroblastoma but faces challenges due to RA resistance.
• RA resistance significantly impacts patient survival rates, necessitating a deeper understanding of its mechanisms.

Purpose of the Study:

• To investigate the molecular mechanisms underlying retinoic acid (RA) resistance in neuroblastoma.
• To identify key signaling pathways and proteins involved in RA-induced cell survival in neuroblastoma cells.

Main Methods:

• Utilized human SH-SY5Y neuroblastoma cells, known for RA tolerance.
• Analyzed the activation of survival kinases Akt and extracellular signal-regulated kinase 1/2 (ERK1/2).
• Investigated downstream pathways including Mdm2, p53, c-Jun N-terminal kinase (JNK), p21, and caspase-3.

Main Results:

• RA treatment activated Akt and ERK1/2, leading to increased phosphorylation and degradation of the ubiquitin ligase Mdm2.
• Sustained p53 signaling, achieved by inhibiting Mdm2 complex formation or activating JNK, significantly reduced cell viability.
• Akt-mediated phosphorylation of p21 promoted complex formation with caspase-3, contributing to cell protection.

Conclusions:

• RA treatment in SH-SY5Y cells enhances survival signaling pathways.
• RA attenuates basal apoptotic pathways, leading to increased cell viability and contributing to RA resistance.
• Targeting these survival and apoptotic pathways could offer new strategies to overcome RA resistance in neuroblastoma.